Effects of the aromatase inhibitor testolactone on human benign prostatic hyperplasia
Data up to Jan 2025
Total Citations Per Year
Abstract
References (13)
The induction of prostatic hypertrophy in the dog with androstanediol.
1976 • 420 citations
Light Microscopic Stereological Analysis of the Normal Human Prostate and of Benign Prostatic Hyperplasia
1979 • 306 citations
Recent Studies on the Mechanism of Action of Testosterone
1972 • 168 citations
Medical Treatment of Benign Nodular Prostatic Hyperplasia with Cyproterone Acetate
1969 • 134 citations
Transrectal Ultrasonic Volume Determination of the Prostate—A Preoperative and Postoperative Study
1982 • 110 citations
Inhibition of Peripheral Aromatization of Androstenedione to Estrone in Postmenopausal Women with Breast Cancer Using Δ1Testololactone*
1979 • 87 citations
Histological changes in the organs of rats injected with œstrone alone or simultaneously with æstrone and testicular hormone
1935 • 72 citations
Development of a model for the induction of estrogen‐related prostatic hyperplasia in the dog and its response to the aromatase inhibitor 4‐hydroxy‐4‐androstene‐3,17‐dione: Preliminary results
1986 • 64 citations
Conversion of Androstenedione to Estrone in Human Fibroblasts Cultured from Prostate, Genital and Nongenital Skin
1979 • 59 citations
Correlation among Prostate Stroma, Plasma Estrogen Levels, and Urinary Estrogen Excretion in Patients with Benign Prostatic Hypertrophy
1978 • 51 citations
[Drug therapy of benign prostatic hyperplasia].
1996 • 17 citations
Benign prostatic hyperplasia
2009 • 5 citations
Inhibition of 5α-reductase activity by natural and synthetic steroids in cultured human genital skin fibroblasts
1988 • 1 citations